Skip to main content

Gadofullerenes and Gadonanotubes: A New Paradigm for High-Performance Magnetic Resonance Imaging Contrast Agent Probes

Buy Article:

$113.00 plus tax (Refund Policy)

Abstract:

In this review, the physicochemical properties and biomedical applications of Gd@C60 (gadofullerenes) and Gd@ Ultra-short Single-walled carbon nanotubes (gadonanotubes) are discussed, especially in regard to the unique benefits of this novel class of materials for Magnetic Resonance Imaging (MRI). The introduction of carbon nanotechnology into biomaterial science has created great opportunity for improving medical diagnostics and therapeutics. In this regard, derivatized gadofullerenes and gadonanotubes offer a new nanoscale paradigm for the design of high-performance MRI contrast agent (CA) probes with efficacies up to 100 times greater than current clinical CAs. Studies show that such CAs are well suited for both passive (magnetic labels for cells) and active (pH-sensitive probes) MRI-based molecular imaging. This capability might lead, for example, to the detection of molecular components or processes that are at the cause of disease. The various important physicochemical factors or parameters discussed in this work provide valuable insight into the development of not only other carbon nanostructure-based MRI contrast agents, but for any fullerene-based biomedical application.

Keywords: BIOMEDICAL APPLICATIONS; CONTRAST AGENTS; GADOFULLERENES; GADONANOTUBES; GD COMMAT C60; MAGNETIC RESONANCE IMAGING (MRI); MOLECULAR IMAGING; NMRD; SINGLE-WALLED CARBON NANOTUBE; US-TUBES

Document Type: Review Article

DOI: https://doi.org/10.1166/jbn.2007.043

Publication date: 2007-12-01

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more